Pharmaceutical

MOMA Therapeutics and Roche sign cancer drug discovery deal

MOMA Therapeutics and Roche have signed a strategic partnership and licensing agreement for discovering drug targets for cancer.

Jan 5, 2024 - 18:00
MOMA Therapeutics and Roche sign cancer drug discovery deal
MOMA Therapeutics and Roche have signed a strategic partnership and licensing agreement for discovering drug targets for cancer.
Read the original article

Tags:

Previous Article

Insilico teams up with Menarini for breast cancer KAT6 inhibitor

Next Article

AbbVie and Umoja to develop new CAR-T therapies for cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Vaxcyte and Lonza sign new commercial manufacturing agreement for PCVs

Vaxcyte and Lonza sign new commercial manufacturing agr...

Oct 17, 2023

STAT+: Longer treatment gave better liver outcomes for MASH patients, Akero drug study shows

STAT+: Longer treatment gave better liver outcomes for ...

Mar 4, 2024

Datopotamab deruxtecan by Daiichi Sankyo for Head And N...

Apr 23, 2024